buprenorphine and cenicriviroc

buprenorphine has been researched along with cenicriviroc* in 1 studies

Other Studies

1 other study(ies) available for buprenorphine and cenicriviroc

Article	Year
Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy. Frontiers in immunology, 2020, Volume: 11 Topics: Analgesics; Analgesics, Opioid; Animals; Buprenorphine; CCR5 Receptor Antagonists; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Imidazoles; Injections, Spinal; Male; Morphine; Nerve Tissue Proteins; Neuralgia; Rats; Rats, Wistar; Receptors, CCR2; Receptors, CCR5; Receptors, Opioid; RNA, Messenger; Sciatic Neuropathy; Spinal Cord; Sulfoxides	2020

Article

Year

Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.

Frontiers in immunology, 2020, Volume: 11

Topics: Analgesics; Analgesics, Opioid; Animals; Buprenorphine; CCR5 Receptor Antagonists; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Imidazoles; Injections, Spinal; Male; Morphine; Nerve Tissue Proteins; Neuralgia; Rats; Rats, Wistar; Receptors, CCR2; Receptors, CCR5; Receptors, Opioid; RNA, Messenger; Sciatic Neuropathy; Spinal Cord; Sulfoxides

2020